Atlas Trials

Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection

Clinical trial NCT04335552 · TERMINATED

Trial details

NCT number
NCT04335552
Sponsor
Duke University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
SARS-CoV-2
Start date
2020-04-17
Primary completion
2020-06-17
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.